Eggnovo's eggshell membrane ingredient has received Novel Food approval in Europe, marking a significant milestone in the evolution of eggshell membrane technology. This approval opens up new opportunities for functional ingredient innovation across the health and nutrition markets, particularly in the areas of healthy aging, joint health, mobility, and beauty from within. The ingredient, known as egg membrane hydrolysate (enzymatically produced), is a water-soluble protein hydrolysate derived from eggshell membranes using a patented water-based extraction process. This process preserves naturally occurring bioactive compounds without the use of harsh chemicals.
One of the key advantages of this ingredient is its ability to be used in highly demanded liquid supplement formats. Thanks to Eggnovo's enzymatic process, the ingredient is water-soluble, offering formulation possibilities that have not previously been available within the eggshell membrane category. This makes it possible to bring the clinically validated efficacy of Eggnovo's eggshell membrane ingredients into liquid supplements, which are increasingly popular among consumers.
The approval also allows Eggnovo to expand the application of its technology into additional food and cosmetic sectors. The company's ESM-based collagen ingredients are positioned as a concentrated alternative to traditional animal-derived collagen sources, with a daily intake recommendation of approximately 300 mg, compared with higher daily quantities commonly used for some conventional collagen supplements. This makes it an attractive option for consumers looking for functional ingredients that support joint health, skin hydration and elasticity, hair and nail strength, and general wellness.
In my opinion, the Novel Food approval of Eggnovo's eggshell membrane ingredient is a significant step forward in the development of functional ingredients derived from natural sources. It demonstrates the potential of biotechnology to transform underutilized natural resources into new generation of functional ingredients, and it opens up new opportunities for innovation in the health and nutrition markets. Personally, I think that this approval will lead to a surge in the development of functional ingredients derived from natural sources, as companies seek to capitalize on the growing demand for natural and sustainable ingredients.
However, there are also some challenges and limitations associated with this approval. For example, the ingredient is not suitable for pregnant and breastfeeding women, which may limit its use in certain applications. Additionally, the approval only covers the use of the ingredient in food supplements, and it does not cover its use in other food or cosmetic products. This may limit the potential for innovation in these sectors.
Overall, the Novel Food approval of Eggnovo's eggshell membrane ingredient is a significant milestone in the evolution of eggshell membrane technology. It opens up new opportunities for functional ingredient innovation across the health and nutrition markets, and it demonstrates the potential of biotechnology to transform underutilized natural resources into new generation of functional ingredients. However, there are also some challenges and limitations associated with this approval, and it remains to be seen how it will impact the development of functional ingredients derived from natural sources in the long term.
